‹ Kembali
Dunia

Lilly Pushes Buying Spree Beyond $32B With Calytrix Deal

Sumber: Bloomberg · 1 jam lalu
Recap • TITIR
  • Eli Lilly agrees to buy Calytrix Bio for up to $1.5 billion.
  • Deal is part of Lilly’s $32 billion acquisition wave in 2026.
  • Purchased company focuses on cancer and immunology businesses.
  • Sam Fazeli, Bloomberg Intelligence, analyzes biotech and AI’s role in M&A.
  • Lilly’s acquisitions aim to expand cancer and immunology capabilities.
Recap singkat dari artikel aslinya. Bisa aja kurang pas — baca sumber aslinya buat versi lengkap.
Baca sumber

BERITA TERKAIT

Cargo ship capsizes off Bulgaria’s Black Sea coast (Al Jazeera · 56 menit lalu)Several companies are using Trump tariff refunds for corporate bonuses (The Guardian · 58 menit lalu)Pakistan’s jailed ex-leader Imran Khan appeals for urgent medical care (South China Morning Post · 1 jam lalu)Israeli court upholds detention of Palestinian land activist Ghassan Najjar (Al Jazeera · 1 jam lalu)